Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

CSHL1 Inhibitors

CSHL1 Inhibitors constitute a specialized class of chemical compounds designed to selectively impede the activity of the CSHL1 gene product. CSHL1, or Cold Shock Domain-Containing Protein L1, is a member of the cold shock protein family, characterized by the presence of a conserved cold shock domain. These proteins play diverse roles in cellular processes, including RNA binding, transcriptional regulation, and response to environmental stress. The development of inhibitors targeting CSHL1 is crucial for scientific investigations, providing researchers with specific tools to explore the molecular functions and regulatory roles associated with this particular cold shock protein variant.

The synthesis and optimization of CSHL1 inhibitors require a comprehensive understanding of the gene product's structural characteristics and its interactions within cellular pathways. These inhibitors are meticulously designed for specificity, aiming to selectively bind to key regions of CSHL1 and interfere with its normal functions. By employing CSHL1 inhibitors in experimental settings, researchers can explore the consequences of gene product inhibition on cellular processes, shedding light on the specific molecular pathways influenced by CSHL1. The study of CSHL1 inhibitors contributes to the broader exploration of cold shock proteins, providing insights into the intricate molecular machinery that underlies cellular responses to environmental cues and stress conditions.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Mitomycin C

50-07-7sc-3514A
sc-3514
sc-3514B
2 mg
5 mg
10 mg
$66.00
$101.00
$143.00
85
(5)

Mitomycin C cross-links DNA, inhibiting transcription and potentially reducing the synthesis of CSHL1 mRNA.

Puromycin dihydrochloride

58-58-2sc-108071
sc-108071B
sc-108071C
sc-108071A
25 mg
250 mg
1 g
50 mg
$42.00
$214.00
$832.00
$66.00
394
(16)

Puromycin induces premature termination of protein synthesis, impacting translation and lowering CSHL1 levels.

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$74.00
$243.00
$731.00
$2572.00
$21848.00
53
(3)

Actinomycin X2, similar to Actinomycin D, binds to DNA and inhibits transcription, resulting in decreased CSHL1 mRNA.

Mycophenolic acid

24280-93-1sc-200110
sc-200110A
100 mg
500 mg
$69.00
$266.00
8
(1)

Mycophenolic acid inhibits inosine monophosphate dehydrogenase, indirectly affecting CSHL1 expression by disrupting purine synthesis.

Blasticidin S Hydrochloride

3513-03-9sc-204655A
sc-204655
25 mg
100 mg
$367.00
$520.00
20
(2)

Blasticidin S induces premature termination during translation, inhibiting protein synthesis and reducing CSHL1 levels.

Ellipticine

519-23-3sc-200878
sc-200878A
10 mg
50 mg
$145.00
$569.00
4
(1)

Ellipticine intercalates into DNA, disrupting DNA structure and inhibiting transcription, leading to decreased CSHL1 mRNA.

Camptothecin

7689-03-4sc-200871
sc-200871A
sc-200871B
50 mg
250 mg
100 mg
$58.00
$186.00
$94.00
21
(2)

Camptothecin inhibits DNA topoisomerase I, inducing DNA damage and inhibiting transcription, leading to decreased CSHL1 mRNA.

Ellagic Acid, Dihydrate

476-66-4sc-202598
sc-202598A
sc-202598B
sc-202598C
500 mg
5 g
25 g
100 g
$58.00
$95.00
$245.00
$727.00
8
(1)

Ellagic Acid may inhibit CSHL1 expression through its reported anti-cancer and anti-inflammatory properties.

Fluorouracil

51-21-8sc-29060
sc-29060A
1 g
5 g
$37.00
$152.00
11
(1)

5-Fluorouracil interferes with RNA synthesis, affecting the expression of CSHL1 by disrupting the production of mRNA.